Michigan regulators suspended a hemp processor handler license after an investigation identified products with reported delta 9 THC concentrations far above the state's 0.3 percent hemp limit. The case shows why COAs, inventory audits, product classification, and supplier documentation are becoming critical licensing controls.

An explosion at a licensed Oklahoma medical cannabis processor killed two people and damaged numerous neighboring businesses, raising serious questions about extraction safety, fire code compliance, landlord exposure, and insurance. The cause remains under investigation, but the incident shows why a cannabis license must be supported by facility controls that match the actual processing operation.

Researchers found that biogenic silver nanoparticles can trigger cannabis cell cultures to produce measurable THC and CBD even when untreated cells produce none. The early research could eventually influence cannabinoid manufacturing, pharmaceutical supply, quality control, intellectual property, and the economics of traditional cultivation.

The United States has one of the world's largest cannabis markets but remains a minor participant in international medical cannabis trade. Federal medical rescheduling could create new opportunities, but U.S. operators still face established foreign competitors, pharmaceutical quality standards, permitting requirements, logistics costs, and growing domestic production in importing markets.

Viola co founder Al Harrington says sweeping federal hemp restrictions could punish compliant operators just as THC beverages move deeper into mainstream retail. The bigger business issue is whether companies can manage reformulation, packaging, distribution, inventory, and compliance while federal and state rules continue changing.

Virginia's new hemp THC restrictions eliminated a previous CBD to THC ratio allowance and made products containing more than 2 milligrams of total THC per package illegal for hemp retail sale beginning August 15. Hemp businesses are pushing lawmakers for a dedicated hearing as litigation, inventory losses, enforcement exposure, and the state's future adult use cannabis market intensify the fight.